Prognostic variables in newly diagnosed children with acute myeloid leukemia: AML-XH-99.

被引：0
|
作者：
Gu, LJ [1 ]
Tie, LJ [1 ]
Chen, J [1 ]
Pan, C [1 ]
Dong, L [1 ]
Ye, H [1 ]
Chen, J [1 ]
Xue, HL [1 ]
Tang, JY [1 ]
Wang, YP [1 ]
Zou, JY [1 ]
机构：
[1] Shanghai Med Univ 2, Shanghai Childrens Med Ctr, Xinhua Hosp, Dept Hematol Oncol, Shanghai, Peoples R China
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4414
引用
收藏
页码：187B / 187B
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of weight loss and nutritional markers during induction chemotherapy of newly diagnosed acute myeloid leukemia (AML) patients.
    Smith, Zachary
    Vidal, Gabriel
    Machiorlatti, Michael
    Frank, Summer
    Vesely, Sara
    Minh Duc Phan
    Khawandanah, Mohamad Osama
    Cherry, Mohamad Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics
    Shadman, Mazyar
    Gibson, Sarah
    Cotta, Claudiu
    Saunthararajah, Yogen
    Hsi, Eric
    Copelan, Edward
    Kalaycio, Matt
    Sekeres, Mikkael A.
    Sobecks, Ronald
    Effinger, Meagan
    Advani, Anjali S.
    BLOOD, 2010, 116 (21) : 1128 - 1128
  • [23] Leukapheresis in patients newly diagnosed with acute myeloid leukemia
    Villgran, Vipin
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Lim, Seah H.
    Redner, Robert L.
    Im, Annie
    Sehgal, Alison
    Dorritie, Kathleen A.
    Kiss, Joseph E.
    Normolle, Daniel
    Boyiadzis, Michael
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 55 (02) : 216 - 220
  • [24] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Reville, Patrick K.
    Kadia, Tapan
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [25] Updates in the Management of Newly Diagnosed Acute Myeloid Leukemia
    Mims, Alice S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1358 - 1361
  • [26] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Patrick K. Reville
    Tapan Kadia
    Current Treatment Options in Oncology, 2020, 21
  • [27] Outcome of Newly Diagnosed Acute Myeloid Leukemia (AML) Refractory to 1 or 2 Cycles of Induction Chemotherapy
    Zarzour, Ahmad
    Nazha, Aziz
    Kalaycio, Matt
    Patel, Bhumika J.
    Gerds, Aaron T.
    Clemente, Michael J.
    Hirsch, Cassandra M.
    Carew, Jennifer S.
    Advani, Anjali S.
    Sanikommu, Srinivasa R.
    Przychodzen, Bartlomiej
    Carraway, Hetty E.
    Mukherjee, Sudipto
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2015, 126 (23)
  • [28] Outcome of Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis: Retrospective Study of JALSG AML201
    Matsumoto, Kenji
    Fujisawa, Shin
    Hagihara, Maki
    Honda, Sumihisa
    Ohtake, Shigeki
    Miyawaki, Shuichi
    Sakura, Toru
    Nobuaki, Dobashi
    Ohata, Kinya
    Ozawa, Yukiyasu
    Ou, Iekuni
    Hirose, Asao
    Maeda, Tomoya
    Ito, Yoshikazu
    Doki, Noriko
    Kiyoi, Hitoshi
    Ohnishi, Kazunori
    Naoe, Tomoki
    Miyazaki, Yasushi
    Nakajima, Hideaki
    BLOOD, 2016, 128 (22)
  • [29] Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia - A report from the children's cancer group
    Dusenbery, KE
    Howells, WB
    Arthur, DC
    Alonzo, T
    Lee, JW
    Kobrinsky, N
    Barnard, DR
    Wells, RJ
    Buckley, JD
    Lange, BJ
    Woods, WG
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (10) : 760 - 768
  • [30] FLT 3 mutation and its prognostic significance in newly diagnosed acute myeloid leukemia in adults
    Lokadasan, R.
    Narayanan, G.
    Sreejith, N. G.
    Prakash, N.
    Hariharan, S.
    Aswathy, C.
    ANNALS OF ONCOLOGY, 2017, 28 : 97 - 97
12345